Metoclopramide Hydrochloride Prices

Metoclopramide Hydrochloride Price Trend, Index and Forecast

Track the latest insights on metoclopramide hydrochloride price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Metoclopramide Hydrochloride Prices Outlook Q2 2025

• USA: US$ 140310/MT
• China: US$ 125410/MT
• Germany: US$ 145665/MT
• Mexico: US$ 122780/MT
• Brazil: US$ 131580/MT

Metoclopramide Hydrochloride Price Chart

Get real-time access to monthly/quaterly/yearly prices, Request Sample

During the second quarter of 2025, the metoclopramide hydrochloride prices in the USA reached 140310 USD/MT in June. In the USA, metoclopramide hydrochloride prices were influenced by steady demand from hospitals, clinics, and pharmaceutical distributors. Domestic production costs were shaped by feedstock availability, energy tariffs, and labor expenses. Imports from Asia supplemented supply, with landed costs affected by freight charges, port handling, and customs documentation. Compliance with Food and Drug Administration regulations for quality and safety added testing and certification costs. Inland logistics, including warehousing and long-haul trucking, further contributed to distribution expenses.

During the second quarter of 2025, metoclopramide hydrochloride prices in China reached 125410 USD/MT in June. In China, metoclopramide hydrochloride prices were driven by demand from domestic healthcare systems and pharmaceutical manufacturers, as well as exports to global markets. Production economics were influenced by the availability of raw materials, energy tariffs, and local labor conditions. Export volumes to North America and Europe impacted domestic allocation. Inland transport, port congestion, and shipping costs added to supply chain pressures, while compliance with pharmaceutical safety and environmental regulations increased overall production-related expenses.

During the second quarter of 2025, the metoclopramide hydrochloride prices in Germany reached 145665 USD/MT in June. In Germany, metoclopramide hydrochloride prices were shaped by consumption in the healthcare and pharmaceutical manufacturing sectors. Supply relied on both domestic production and imports, with freight charges, customs duties, and port handling shaping landed costs. High energy tariffs and labor costs influenced production economics, while strict European Union regulations required comprehensive testing and certification, adding compliance-related expenses. Inland distribution, including warehousing and trucking across multiple countries, further contributed to procurement and supply chain costs.

During the second quarter of 2025, the metoclopramide hydrochloride prices in Mexico reached 122780 USD/MT in June. In Mexico, metoclopramide hydrochloride prices were influenced by demand from hospitals, pharmacies, and pharmaceutical distributors. Supply was supported by a mix of domestic production and imports, with landed costs affected by international shipping rates, port logistics, and customs clearance. Currency fluctuations against the US dollar played a significant role in procurement expenses. Domestic logistics, including road transport and storage, added to overall supply chain costs, while regulatory compliance with national pharmaceutical safety standards increased certification expenses.

During the second quarter of 2025, the metoclopramide hydrochloride prices in Brazil reached 131580 USD/MT in June. In Brazil, metoclopramide hydrochloride prices were guided by demand from public and private healthcare providers. Limited domestic production created reliance on imports, making costs sensitive to global freight rates, port inefficiencies, and customs regulations. Currency volatility of the Brazilian real against the US dollar strongly influenced procurement dynamics. Domestic logistics challenges, including long-haul trucking and infrastructure limitations, added to supply chain costs. Compliance with national health authority regulations further increased certification and quality assurance expenses for both importers and distributors.

Metoclopramide Hydrochloride Prices Outlook Q2 2023

• USA: US$ 131500/MT
• China: US$ 127320/MT
• Germany: US$ 134750/MT

In the U.S., the price of metoclopramide hydrochloride reached 131500 USD/MT in June 2023, with a slight increase of 1.18% in May, driven by heightened end-user demand and fresh inventory replenishments. The presence of abundant domestic inventory, coupled with high-interest rates and a stronger U.S. dollar against the Chinese yuan, contributed to the downward pressure on prices in June.

In China, the price of metoclopramide hydrochloride reached 127320 USD/MT in June 2023, with a 1.21% rise in May from April due to consistent domestic demand and ongoing operational activity. Prices declined by 3.21% in June, influenced by reduced new order follow-ups and slowing consumer purchasing, with the PMI slightly improving to 49.0 but still reflecting sluggish manufacturing activity. The fall in Chinese exports by 12.4% in June further increased local availability, contributing to the price decrease.

In Germany, the price of metoclopramide hydrochloride reached 134750 USD/MT in December 2023, with a rise in May due to limited stockpiles and increased end-user demand, despite a declining manufacturing PMI from 44.5 in April to 43.2 in May indicating weaker business activity. Prices then fell by 4.38% in June, influenced by rising inflation and an interest rate hike by the European Central Bank, which escalated living costs and reduced consumer purchasing activity.

Regional Coverage

The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the metoclopramide hydrochloride prices.

Global Metoclopramide Hydrochloride Price Trend

The report offers a holistic view of the global metoclopramide hydrochloride pricing trends in the form of metoclopramide hydrochloride price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price levels but also provides insights into historical price of metoclopramide hydrochloride, enabling stakeholders to understand past fluctuations and their underlying causes. The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed metoclopramide hydrochloride demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Metoclopramide Hydrochloride Price Trend

Q2 2025:

As per the metoclopramide hydrochloride price index, European prices were shaped by demand from hospitals, clinics, and pharmaceutical distributors. Supply was influenced by both domestic production and imports from Asia, with freight charges, port operations, and customs duties affecting landed costs. High energy tariffs and labor expenses increased production pressures within the region. Compliance with European Union pharmaceutical regulations, including rigorous testing, traceability, and certification, added to operational costs. Inland logistics, including cross-border trucking and warehousing, further contributed to procurement dynamics across key healthcare markets.

Q2 2023:

In the European market, metoclopramide hydrochloride prices saw varied trends in Q2. Prices initially rose by 1.19% in May due to limited stockpiles and heightened demand but fell by 4.38% in June. Economic challenges were evident as Germany's Manufacturing PMI dropped, reflecting weakened activity and supply chain issues. Further, there was an increase in the living costs due to rising inflation, and the ECB’s interest rate going up reduced demand hence lowering the prices. This shows how the European pharmaceutical markets were sensitive to general economic conditions; the appreciation of the euro made imports cheaper and boosted the supply, thus lowering the prices.

This analysis can be extended to include detailed metoclopramide hydrochloride price information for a comprehensive list of countries.

North America Metoclopramide Hydrochloride Price Trend

Q2 2025:

As per the metoclopramide hydrochloride price index, in North America, metoclopramide hydrochloride prices were influenced by demand from hospitals, pharmacies, and large healthcare networks. Supply relied on domestic production supplemented by imports, with freight rates, customs documentation, and port congestion shaping landed costs. Feedstock availability and production inputs influenced manufacturing expenses, while compliance with stringent Food and Drug Administration regulations added certification and quality assurance costs. Inland distribution, including warehousing and long-haul trucking, further increased expenses, particularly given the extensive healthcare distribution system across the region.

Q2 2023:

In the second quarter of 2023, the price of Metoclopramide hydrochloride in the North American market transitioned with relatively unstable features. Further, may last year recorded an average inflation rate of one percent for prices. by 18% due to the rising need of the end-users, and restocking from new inventory stock, although the Manufacturing PMI was 48. That is equal to 4 which signal a slowdown in the US manufacturing industry. This meant while manufacturers supplied low quantities to the market, consumers’ demand was high, and this led to a rise in prices. On the other hand, for June, the price fell by 4. 23% was declined due to weak demand from the end-use sectors. Furthermore, high Federal Reserve interest rates reduced market demand, while the rise in the U.S. dollar value weakened the Chinese yuan, and thus, placed upward pressure on imports and consequently on depressing prices. This led to the establishment of a mixed-price trend of metoclopramide hydrochloride in the particular region.

Specific metoclopramide hydrochloride historical data within the United States and Canada can also be provided.

Middle East and Africa Metoclopramide Hydrochloride Price Trend

Q2 2025:

As per the metoclopramide hydrochloride price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences. A tight supply from refineries, exacerbated by maintenance rounds and unplanned outages, put pressure on prices. Simultaneously, demand from the agrochemical sector during the planting season contributed to price changes.

Q2 2023:

The report explores the metoclopramide hydrochloride pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on metoclopramide hydrochloride prices for countries can also be provided.

Asia Pacific Metoclopramide Hydrochloride Price Trend

Q2 2025:

In Asia Pacific, metoclopramide hydrochloride prices were driven by demand from pharmaceutical producers, hospitals, and export markets, with China and India acting as key suppliers. Production economics were shaped by the availability of fermentation feedstocks, energy tariffs, and local labor conditions. Export volumes to Europe and North America influenced domestic allocation, while inland transportation and port handling costs impacted logistics expenses. Regulatory compliance with international standards, such as Good Manufacturing Practices, added further costs, particularly for exporters serving highly regulated markets abroad.

Q2 2023:

Metoclopramide hydrochloride in Asia Pacific, there were fluctuating movements of the market even in the second quarter. The inflation was recorded to be standing at 1 percent higher in May as compared to the earlier months. 21% attributing it to stead manufactures and regular operations within the domestic market and at the same time, China’s Purchasing Managers Index (PMI) has dropped to 48. 8, suggesting that the original manufacturing rate had slightly decreased and suppliers had lower inventories than before. However, in June, prices declined by 3.21% as manufacturing activity continued to slow, with the PMI slightly recovering to 49.0, and consumer purchasing and new order follow-ups decreased. Additionally, a significant drop in Chinese exports by 12.4% contributed to an increase in local supply, further driving down prices. This fluctuation reflects the dynamic nature of the metoclopramide hydrochloride market in the Asia Pacific, influenced by both internal production factors and external economic conditions.

This metoclopramide hydrochloride price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Metoclopramide Hydrochloride Price Trend

Q2 2025:

In Latin America, especially Brazil, metoclopramide hydrochloride prices were shaped by demand from public and private healthcare providers. Limited domestic production increased reliance on imports, making procurement highly sensitive to international shipping charges, port inefficiencies, and customs clearance. Currency volatility of the Brazilian real against the US dollar significantly influenced landed expenses. Domestic logistics challenges, including long-haul trucking and infrastructure limitations, added to distribution costs. Compliance with national pharmaceutical regulations further increased testing and certification requirements, shaping procurement strategies across the regional market.

Q2 2023:

The analysis of metoclopramide hydrochloride prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Metoclopramide Hydrochloride Price Trend, Market Analysis, and News

IMARC's latest publication, “Metoclopramide Hydrochloride Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the metoclopramide hydrochloride market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of metoclopramide hydrochloride at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed metoclopramide hydrochloride prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting metoclopramide hydrochloride pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

Metoclopramide Hydrochloride Industry Analysis

The global metoclopramide hydrochloride market size reached USD 4.76 Billion in 2024. By 2033, IMARC Group expects the market to reach USD 6.43 Billion, at a projected CAGR of 3.23% during 2025-2033.

• The increasing prevalence of gastrointestinal disorders among the global population, coupled with rising healthcare expenditure are fueling the market.
• The growing geriatric population, which is more susceptible to digestive ailments requiring such treatments, further amplifies market expansion.
• The pharmaceutical industry's focus on research and development has led to improved formulations of metoclopramide hydrochloride, enhancing its efficacy and patient tolerance, thereby bolstering its adoption across medical facilities.
• The escalating emphasis on patient care standards and the need for effective management of chemotherapy-induced nausea and surgical recoveries, the demand for reliable antiemetic medications continues to rise.
• The growing introduction of generic versions has made this medication more accessible and cost-effective, supporting its widespread use in various healthcare systems globally.
• The increased focus on personalized medicine is another driver, with more targeted treatments being developed based on individual patient needs and genetic profiles.
• Strategic collaborations and partnerships between pharmaceutical companies and research institutions are leading to more robust research pipelines and faster market introductions of enhanced metoclopramide formulations.
• New formulations that offer controlled or extended release of metoclopramide hydrochloride enhance patient compliance and efficacy of the treatment, making the drug more appealing to both providers and patients.
• Healthcare providers are increasingly recommending metoclopramide hydrochloride as a standard part of treatment regimens to prevent nausea and enhance patient comfort, driven by clinical guidelines and patient satisfaction metrics.
• As countries develop their healthcare systems, the distribution and availability of essential drugs like metoclopramide hydrochloride improve, enabling better management of conditions such as nausea and gastroparesis.
• Ongoing educational programs aimed at healthcare professionals about the benefits and correct usage of metoclopramide hydrochloride can increase its utilization effectively.
• Innovations in drug packaging and delivery systems that enhance the stability, shelf life, and dosing accuracy of pharmaceuticals like metoclopramide hydrochloride also contribute to its market growth.
• Governmental and non-governmental health initiatives focusing on improving gastrointestinal health can lead to increased awareness and diagnosis of conditions like gastroparesis and severe nausea, subsequently driving up the demand for effective treatments such as metoclopramide hydrochloride.

Metoclopramide Hydrochloride News

The report covers the latest developments, updates, and trends impacting the global metoclopramide hydrochloride market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in metoclopramide hydrochloride production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the metoclopramide hydrochloride price trend.

Latest developments in the metoclopramide hydrochloride industry:

• February 2024: Evoke Pharma, a specialty pharmaceutical company, has announced the closing of a $7.5 million public offering, with the potential for an additional $22.5 million if the common warrants are exercised in full. The company's focus is on developing treatments for gastrointestinal diseases, including metoclopramide, a medication used to treat gastroparesis and other digestive issues.

Product Description

Metoclopramide hydrochloride is an antiemetic often used in cases of nausea and vomiting, delayed stomach emptying, or gastroparesis. It also assists in the treatment of gastroesophageal reflux disease widely referred to as GERD as well as postoperative nausea and vomiting when used as a complementary treatment with chemotherapy or surgery. They are effective through their receptors’ antagonism of dopamine within the chemoreceptor trigger zone of the gastrointestinal tract and additionally, it influences the serotonin receptors.

The production process of metoclopramide hydrochloride entails chemical synthesis in which organic reactions leading to the formation of API are carried out. This process is carried out under regulation to make sure that the drug is pure and will achieve the intended goal that it was manufactured for. The role of metoclopramide hydrochloride stems from the relief of such profound symptoms of nausea and retarded gastric motility, which is a genuine detriment to a patient’s lifestyle. It applies to almost all clinical conditions and is considered a significant component of therapeutic interfaces for patients with different GI and chemotherapy problems.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of metoclopramide hydrochloride pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting metoclopramide hydrochloride price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The metoclopramide hydrochloride price charts ensure our clients remain at the forefront of the industry.